RPS6KB1 and prostate carcinoma: For example, IL-8 has been shown to promote the proliferation of prostate cancer through the activation of AKT-mTOR, resulting in the downstream phosphorylation of 4E-BP1 and PS6K, which could be abrogated by rapamycin (29).